#MedTwitter 'Recently published 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria reflect the current thinking about APS, providing high specificity and a strong foundation for future APS research.' — Doruk Erkan, MD, MPH (Doruk Erkan) pubmed.ncbi.nlm.nih.gov/37635643/

.American College of Rheumatology & EULAR unveiled a new classification criteria for #antiphospholipidsyndrome led by HSS rheumatologists Drs. Doruk Erkan (@DorukErkanMD) & Medha Barbhaiya (@MBarbhaiya), and Dr. Stephane Zuily (@szuily) from Université de Lorraine news.hss.edu/2023-acreular-… #HSSRheum

Thanks #ACR22 for the opportunity to present Draft #APS Classification Criteria (pending ACR/EULAR approval). Our Core Planning group (Stéphane ZUILY, Francis Guillemin, Alison Hendry, Doruk Erkan, Medha Barbhaiya, Karen Costenbader, no pic Manneville Florian) is grateful to all contributors!

Phenomenal presentation by Sara Tedeschi on the Draft ACR/EULAR #CPPD classification criteria today at #ACR22 ! Can’t wait to see the final published criteria!

Beyond deserving! Can’t wait to see this on Saturday! HSS Education Institute HSS Physician-in-Chief #ACR22

NEW COMMENT—Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of #COVID19 vaccination thelancet.com/journals/lanrh… #LancetRheumatology
Medha Barbhaiya Jonah Levine Vivian Bykerk Lisa A. Mandl MD MPH

Early view Special Article in ACR Open Access:

When a Diagnosis Has No Name: Uncertainty and Opportunity

onlinelibrary.wiley.com/doi/full/10.10…

HSS rheumatologists Drs. Medha Barbhaiya (Medha Barbhaiya) and Lisa Mandl (@LisaAMandlMD) discuss their #ACR21 study results finding potential risk factors for long-haul #COVID19 in rheumatic disease patients #HSSRheum (via @creakyjoints). fal.cn/3k5au

Phenomenal work and presentation by Jonah Levine at #ACR21 . Not yet a medical student, but he nailed his oral presentation on medication modifications at the time of #COVID19 vaccination! Hospital for Special Surgery (HSS) Lisa A. Mandl MD MPH Vivian Bykerk

Fear of #SLE disease flare most commonly cited reason for #COVID vaccine refusal in #lupus patients, yet #ACR21 study from Hospital for Special Surgery (HSS) Medha Barbhaiya Jonah Levine Vivian Bykerk shows 91% of #lupus patients did not experience a disease flare. Of those who did, most were mild.

Fantastic work by APS_ACTION members, helping to advance our current understanding of the complicated #antiphospholipid syndrome Hospital for Special Surgery (HSS) #ACR21

Hopefully reassuring data for our patients with #lupus —over 91% did not report a disease flare after COVID-19 vaccination. Lisa A. Mandl MD MPH Jonah Levine Hospital for Special Surgery (HSS) #ACR21

The antiphospholipid antibody and COVID-19 story has come a very long way, but we are still learning more. ICYMI, be sure to watch Elena Gkrouzman Jason S Knight Hannah Cohen at the #ACR21 APS study group.
Doruk Erkan

On Monday, APS ACTION Members will Discuss the Association Between Antiphospholipid Antibodies and COVID-19 at the #ACR21 American College of Rheumatology Annual Scientific Meeting #APS Study Group. Medha Barbhaiya Jason S Knight Elena Gkrouzman Hannah Cohen Doruk Erkan

Proud to be part of this team at #ACR21 !@HSpecialSurgery
Check us out:
ow.ly/tjCR50GxZZf

The B-cell story in lupus continues to evolve…it was fun to write this with Kat Liao!

May this data provide some reassurance and help with vaccine decision making by patients with rheumatic diseases bit.ly/2TMYEi8

Lisa A. Mandl MD MPH Jonah Levine Vivian Bykerk HSS Education Institute Annals of the Rheumatic Diseases #rheumtwitter

Congrats Caroline H. Siegel and Juliette Kleinman on this work!

This week the Barbara Volker Center for Women and Rheumatic Diseases at HSS is hosting a conference titled “When the Illness Has No Name,” to address the topic of diagnostic uncertainty. Learn more: news.hss.edu/bringing-atten…. #HSSRheum

An HSS study published in Arthritis Care & Research shows pregnancy is not linked to increased self-reported #COVID19 , but is to a shorter duration of symptoms & a higher prevalence of loss of smell or taste, in patients with rheumatic disease. #HSSRheum news.hss.edu/study-investig…